|
6ZBV
Inward-open structure of human glycine transporter 1 in complex with a benzoylisoindoline inhibitor and sybody Sb_GlyT1#7
提交 2020-06-09
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 A
91–239(149 aa)
链 A
257–684(428 aa)
|
未记录
|
QET [5-fluoranyl-6-(oxan-4-yloxy)-1,3-dihydroisoindol-2-yl]-[5-methylsulfonyl-2-[2,2,3,3,3-pentakis(fluoranyl)propoxy]phenyl]methanone × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
LIPIDIC CUBIC PHASE;pH 7;292.75 K;0.1M ADA pH 7, 13-25% PEG600, 4-14% v/v-1,3-Butanediol
|
分辨率 3.40 Å
R-free 0.259
|
|
6ZPL
Inward-open structure of human glycine transporter 1 in complex with a benzoylisoindoline inhibitor, sybody Sb_GlyT1#7 and bound Na and Cl ions.
提交 2020-07-08
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 5
PDB 声明:pentameric
|
链 A
92–684(593 aa)
链 B
92–684(593 aa)
|
突变:;L153A, S297A, I368A, C633A. N-terminal deletion of residues 1-91 and residues 9-281 of Lichenase (PDB ID 2CIT) have been fused at the N-terminal. C- terminal deletion of residues 685-706 as well as a deletion in the extracellular loop 2 (EL2) between residues 240-256.
;
突变:;L153A, S297A, I368A, C633A. N-terminal deletion of residues 1-91 and residues 9-281 of Lichenase (PDB ID 2CIT) have been fused at the N-terminal. C- terminal deletion of residues 685-706 as well as a deletion in the extracellular loop 2 (EL2) between residues 240-256.
;
|
QET [5-fluoranyl-6-(oxan-4-yloxy)-1,3-dihydroisoindol-2-yl]-[5-methylsulfonyl-2-[2,2,3,3,3-pentakis(fluoranyl)propoxy]phenyl]methanone × 2
NA SODIUM ION × 2
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
LIPIDIC CUBIC PHASE;pH 7;292.75 K;Crystals appeared in 3-10 days in 0.1 M ADA pH 7, 13-25% PEG600, 4-14% v/v, 1,3-Butanediol with the longest dimension of 2-5 um.
|
分辨率 3.94 Å
R-free 0.291
|
|
8WFI
human glycine transporter 1 in complex with glycine in occluded conformation
提交 2023-09-19
|
构建体不同
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
46–614(569 aa)
|
未记录
|
GLY GLYCINE × 1
CL CHLORIDE ION × 1
NA SODIUM ION × 2
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.58 Å
|
|
8WFK
human glycine transporter 1 in complex with SSR504734 in outward facing conformation
提交 2023-09-19
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–652(652 aa)
|
未记录
|
W5O SSR504734 × 1
CL CHLORIDE ION × 1
NA SODIUM ION × 2
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.22 Å
|
|
8WFL
human glycine transporter 1 in complex with PF-03463275 in outward facing conformation
提交 2023-09-19
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–652(652 aa)
|
未记录
|
W5X PF-3463275 × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.03 Å
|
|
9J8B
Human Glycine Transporter 1 in the Apo State with an Inward-Facing Conformation
提交 2024-08-21
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–652(652 aa)
|
未记录
|
未记录非水小分子
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.90 Å
|
|
9J8C
Human Glycine Transporter 1 in the Sarcosine-Bound State with an Occluded Conformation
提交 2024-08-21
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–652(652 aa)
|
未记录
|
SAR SARCOSINE × 1
CLR CHOLESTEROL × 3
CL CHLORIDE ION × 1
NA SODIUM ION × 2
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.90 Å
|
|
9J8D
Human Glycine Transporter 1 in the Iclepertin-Bound State with an Inward-Facing Conformation
提交 2024-08-21
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–652(652 aa)
|
未记录
|
A1EBX Iclepertin × 1
CL CHLORIDE ION × 1
CLR CHOLESTEROL × 3
NA SODIUM ION × 2
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.00 Å
|